Amneal Pharmaceuticals Inc (AMRX)
NASDAQ:AMRX
Holding AMRX?
Track your performance easily

Amneal Pharmaceuticals (AMRX) Financial Statements

470 Followers

Amneal Pharmaceuticals Financial Overview

Amneal Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.623; its P/E ratio is -13.97; Amneal Pharmaceuticals is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $0.13. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 701.78M$ 659.19M$ 616.98M$ 620.04M$ 599.05M
Gross Profit$ 249.95M$ 238.06M$ 189.83M$ 232.53M$ 220.02M
EBIT$ 33.85M$ -73.57M$ -78.88M$ 22.96M$ 29.66M
EBITDA$ 90.35M$ -17.76M$ -20.65M$ 82.52M$ 89.24M
Net Income Common Stockholders$ 5.99M$ -91.64M$ -98.65M$ 9.68M$ 11.92M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 43.77M$ 46.52M$ 91.54M$ 86.93M$ 114.58M
Total Assets$ 3.51B$ 3.46B$ 3.47B$ 3.69B$ 3.70B
Total Debt$ 2.58B$ 2.63B$ 2.64B$ 2.69B$ 2.74B
Net Debt$ 2.54B$ 2.59B$ 2.55B$ 2.60B$ 2.63B
Total Liabilities$ 2.70B$ 2.75B$ 2.72B$ 2.77B$ 2.82B
Stockholders Equity$ -57.47M$ -63.72M$ 19.78M$ 330.86M$ 318.17M
Cash Flow-
Free Cash Flow$ 28.28M$ -23.31M$ 106.06M$ 64.82M$ -18.13M
Operating Cash Flow$ 39.66M$ -4.41M$ 135.82M$ 77.48M$ -4.98M
Investing Cash Flow$ -6.46M$ -19.76M$ -31.69M$ -9.57M$ -18.65M
Financing Cash Flow$ -35.09M$ -23.16M$ -100.83M$ -86.58M$ -12.26M
Currency in USD

Amneal Pharmaceuticals Earnings and Revenue History

Amneal Pharmaceuticals Debt to Assets

Amneal Pharmaceuticals Cash Flow

Amneal Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis